The results aren’t all positive – Trelegy wasn’t able to improve on Relvar/Breo when it came to reducing asthma exacerbations and two other doses of Trelegy didn’t perform better than the ...

Trelegy may well cannibalise sales of GSK's newer double therapy, Breo Ellipta, which is slowly gaining market share. The FDA has given Trelegy a licence for long-term, second line maintenance use ...

Fluticasone furoate, umeclidinium, vilanterol 100/62.5/25mcg, 200/62.5/25mcg; per inh; dry pwd for oral inhalation. Trelegy Ellipta is supplied as a disposable light grey and beige plastic inhaler ...